IQVIA Stock Price

-0.66 (-0.25%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
IQVIA Holdings Inc IQV NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.66 -0.25% 261.61 18:00:18
Open Price Low Price High Price Close Price Prev Close
261.91 259.0401 263.52 261.61 262.27
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
13,801 715,939 $ 260.92 $ 186,801,938 - 146.00 - 265.34
Last Trade Time Type Quantity Stock Price Currency
19:00:00 62,902 $ 261.61 USD


Draw Mode:

IQVIA Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 50.13B 191.61M 169.34M $ 11.36B $ 553.18M 1.43 83.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -8.45k 5.40%

more financials information »


Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IQV Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week257.63264.01249.8266257.75666,1383.981.54%
1 Month259.42265.34249.8266259.61572,4172.190.84%
3 Months247.41265.34238.17251.96697,81814.205.74%
6 Months187.26265.34184.305237.59885,19174.3539.7%
1 Year149.75265.34146.00205.78928,700111.8674.7%
3 Years127.24265.3481.79156.751,181,469134.37105.6%
5 Years102.67265.3481.79146.351,155,603158.94154.81%

IQVIA Description

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The Research & Development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The Technology & Analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210926 06:48:26